Author

Gautam Sethi

National University of Singapore - Cited by 49,610 - Cancer Pharmacology

Biography

Assistant Professor, Yong Loo Lin School of Medicine National University of Singapore, Singapore After completion of his Ph.D research in Cellular Immunology from Banaras Hindu University India, Dr. Sethi joined University of Texas MD Anderson Cancer Center, and worked in the area of inflammation and cancer research for his post-doctoral studies. He later joined National University of Singapore in 2008 as an Assistant Professor and is currently leading the Cancer Pharmacology program in the Department of Pharmacology.  
Title
Cited by
Year
(Nano) platforms in bladder cancer therapy: Challenges and opportunities
M Ashrafizadeh, A Zarrabi, H Karimi‐Maleh, A Taheriazam, S Mirzaei, ...Bioengineering & Translational Medicine 8 (1), e10353, 2023202
38
2023
Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions
HS Tuli, R Joshi, G Kaur, VK Garg, K Sak, M Varol, J Kaur, SA Alharbi, ...Journal of Nanostructure in Chemistry (3), 321-348, 2023202
13
2023
(Nano) platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy
M Ashrafizadeh, A Zarrabi, A Bigham, A Taheriazam, Y Saghari, S Mirzaei, ...Medicinal Research Reviews, 2023202
8
2023
Interplay of dietary antioxidants and gut microbiome in human health: What has been learnt thus far?
N Naliyadhara, A Kumar, SK Gangwar, TN Devanarayanan, M Hegde, ...Journal of Functional Foods 100, 105365, 2023202
7
2023
Natural compounds targeting nuclear receptors for effective cancer therapy
M Hegde, S Girisa, N Naliyadhara, A Kumar, MS Alqahtani, M Abbas, ...Cancer and Metastasis Reviews, 1-58, 2022202
7
2022
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
M Ashrafizadeh, CD Mohan, S Rangappa, A Zarrabi, K Hushmandi, ...Medicinal Research Reviews, 2023202
7
2023
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection
HS Tuli, VK Garg, S Bhushan, V Uttam, U Sharma, A Jain, K Sak, V Yadav, ...Translational Oncology 2, 101596, 2023202
7
2023
Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models
J Zhang, YY Jung, CD Mohan, A Deivasigamani, A Chinnathambi, ...Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 189 (12), 119344, 2022202
6
2022
Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis
HS Tuli, J Kaur, K Vashishth, K Sak, U Sharma, R Choudhary, T Behl, ...Archives of Toxicology 97 (1), 103-120, 2023202
6
2023
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
HL Ang, CD Mohan, MK Shanmugam, HC Leong, P Makvandi, ...Medicinal research reviews 43 (4), 1141-1200, 2023202
6
2023
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
SQ Sin, CD Mohan, RMWJ Goh, M You, SC Nayak, L Chen, G Sethi, ...Cancer and Metastasis Reviews, 1-24, 2022202
5
2022
Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects
HS Tuli, VK Garg, JK Mehta, G Kaur, RK Mohapatra, K Dhama, K Sak, ...OncoTargets and Therapy, 1419-1448, 2022202
5
2022
Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives
M Hegde, N Naliyadhara, J Unnikrishnan, MS Alqahtani, M Abbas, ...Cancer Letters, 216066, 2023202
4
2023
Brassinin induces apoptosis, autophagy, and paraptosis via MAPK signaling pathway activation in chronic myelogenous leukemia cells
MH Yang, IJ Ha, SG Lee, J Lee, JY Um, G Sethi, KS AhnBiology 12 (2), 07, 20220
3
2023
Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements
G Sethi, P Rath, A Chauhan, A Ranjan, R Choudhary, S Ramniwas, K Sak, ...Pharmaceutics 15 (2), 712, 20220
3
2023
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
A Kumar, S Girisa, MS Alqahtani, M Abbas, M Hegde, G Sethi, ...Cells 12 (5), 810, 20220
3
2023
Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update
DS Gupta, V Gadi, G Kaur, M Chintamaneni, HS Tuli, S Ramniwas, ...Biomedicines 11 (1), 221, 20220
3
2023
Dual Effects of miR-181b-2-3p/SOX21 Interaction on Microglia and Neural Stem Cells after Gamma Irradiation
Dual Effects of miR-181b--3p/SOX1 Interaction on Microglia and Neural Stem Cells after Gamma IrradiationH Wang, ZW Ma, FM Ho, G Sethi, FR TangCells 1 (4), 649, 030
2
2023
Fangchinoline abrogates growth and survival of hepatocellular carcinoma by negative regulation of c‐met/HGF and its associated downstream signaling pathways
YY Jung, JY Um, G Sethi, KS AhnPhytotherapy Research 36 (1), 454-4557, 0
2
2022
Long noncoding RNAs induced control of ferroptosis: Implications in cancer progression and treatment
W Shi, G SethiJournal of Cellular Physiology 38 (5), 880-895, 030
2
2023

Referred From: https://scholar.google.co.in/citations?user=pYHIbvgAAAAJ&hl=en

Cited by
Citations 49610
h-index 136
i10-index 389
Recommended Journals
Open Access Journals